Invivyd, Inc.

Healthcare · Biotechnology · United States

Last price 0.5817 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 171.46M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatmen...